CLASS II Device recall · Reported 20 Jul 2016 · FDA Enforcement Report

Mammotome Revolve Dual Vacuum Assist Biopsy System recalled

Devicor Medical Products is recalling Mammotome Revolve Dual Vacuum Assist Biopsy System, distributed in 26 states. The recall was initiated on 19 May 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMST1009 - Lot F11537107D1 Exp. Date 9-Sept, 2018; MST0815 Lot F11536423D1 Exp. Date 8-Sept, 2018; and, MST1009 Lot F11537109D1 Exp. Date 10-Sept, 2018.
Quantity recalledF11537107D1 = 360; F11536423D1 = 80; F11537109D1 = 360

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2211-2016
FDA event ID
74297
Recalling firm
Devicor Medical Products, Cincinnati, OH
Classification
Class II
Status
Terminated
Recall initiated
19 May 2016
FDA classified
14 Jul 2016
Reported
20 Jul 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

19 May 2016Recall initiated by company
14 Jul 2016Classified by FDA+56 days
20 Jul 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A 10 Gauge needle, 9cm long was shipped in an 8 Gauge needle, 15 cm package.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Mammotome Revolve Dual Vacuum Assist Biopsy System Model number: MST1009 & MST0815. Each disposable probe is packaged within a thermoformed tray and covered with a pre-printed (product code and graphics) Tyvek lid. Each tray is labeled on-demand after sealing with a lot number and expiration date. Trays are kitted into sets of five probes and packaged within a sales carton. Two sales cartons are then packed into a corrugated case and shipped to the global distribution center. Device is labeled as sterile. Intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality.

Where it was distributed

Worldwide Distribution -- USA, including the states of AL, AR, CA, CT, DC, FL, GA, IL, KS, KY, LA, MA, MD, ME, MI, MN, MS, NC, NJ, NY, OH, PA, SC, TN, WA and WI; and, the countries of Canada and Japan, Korea, and The Netherlands.

AlabamaArkansasCaliforniaConnecticutDistrict of ColumbiaFloridaGeorgiaIllinoisKansasKentuckyLouisianaMassachusettsMarylandMaineMichiganMinnesotaMississippiNorth CarolinaNew JerseyNew York

Questions about this recall

Why was it recalled?

A 10 Gauge needle, 9cm long was shipped in an 8 Gauge needle, 15 cm package.

Which lots are affected?

MST1009 - Lot F11537107D1 Exp. Date 9-Sept, 2018; MST0815 Lot F11536423D1 Exp. Date 8-Sept, 2018; and, MST1009 Lot F11537109D1 Exp. Date 10-Sept, 2018.

Where was it sold?

Worldwide Distribution -- USA, including the states of AL, AR, CA, CT, DC, FL, GA, IL, KS, KY, LA, MA, MD, ME, MI, MN, MS, NC, NJ, NY, OH, PA, SC, TN, WA and WI; and, the countries of Canada and Japan, Korea, and The Netherlands.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Devicor Medical Products

All 5

Other Hip & Knee Implants recalls

All 3,097